< View All Plan Studies CYBERKNIFE SYSTEM Right Central Lung Metastasis Case History AGE: 62-year-oldGENDER: Male Medical History Chronic obstructive pulmonary disease (COPD), previous surgery on right lung Chest CT: Suspicious lesion in the right lower lobe PET-CT: hypermetabolic nodule, 3.1cm no evidence of regional or distant metastasis Non-Small Cell
< View All Plan Studies CYBERKNIFE SYSTEM Liver Metastasis Case History AGE: 68-year-oldGENDER: Female Medical History Rectal adenocarcinoma diagnosed and treated one year ago: Neoadjuvant chemoradiotherapy, surgical resection, adjuvant chemotherapy Follow-up PET-CT: solitary hypermetabolic lesion in the liver, measuring 2.9cm with no other lesion Planning CT Images Treatment Plan Images
< View All Plan Studies CYBERKNIFE SYSTEM Left Upper Lobe Lung Metastasis Case History AGE: 64-year-oldGENDER: Male Medical History Chronic obstructive pulmonary disease (COPD), previous surgery on left lung Chest CT: Suspicious lesion in the left upper lobe PET-CT: hypermetabolic nodule, 1.8cm no evidence of regional or distant metastasis Hypertension
< View All Plan Studies CYBERKNIFE SYSTEM 8 Brain Metastases Case History AGE: 56-year-oldGENDER: Male Medical History Small Cell Lung Cancer (SCLC), diagnosed and treated eight months ago: Chemotherapy and radiotherapy for the primary lung tumor. No prophylactic cranial irradiation was administered Follow-up MRI: 8 metastases in the brain Planning
< View All Plan Studies CYBERKNIFE SYSTEM One Brain Metastasis Case History AGE: 65-year-oldGENDER: Female Medical History Small Cell Lung Cancer (SCLC), diagnosed and treated six months ago: Surgical resection of the primary lung tumor followed by adjuvant chemotherapy and radiotherapy Patient has been experiencing headaches, dizziness, and occasional balance
< View All Plan Studies CYBERKNIFE SYSTEM Prostate Ultra-hypofraction SBRT Case History AGE: 73-year-old GENDER: Male Medical History Hypertension, hypercholesterolemia, appendectomy Favorable intermediate-risk prostatic adenocarcinoma (NCCN) Initial PSA (iPSA): 9 ng/ml Gleason Score: 3+3=6 (Grade Group 1) Stage: T2b Planning CT Images Patient treated feet first Treatment Plan Images Patient
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Your go-to source for staying informed about our advancements.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.
